PPARG and familial pancreatic carcinoma: Consequently, it is indicated that PPARγ may provide a new molecular biological marker for the early diagnosis of pancreatic cancer and also offer new ways to reinforce the therapy effect of pancreatic cancer and improve its prognosis.